GYGuanghui Yang

Guanghui Yang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Guanghui Yang has a total of 42 co-authors. Here are the top co-authors by number of shared publications:

  • Jurrien Dean

    Laboratory of Cellular and Developmental Biology, NIDDK, National Institutes of Health, Bethesda MD 20892, USA

    5 shared publications
  • Iris Feng

    Laboratory of Cellular and Developmental Biology, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892, USA

    3 shared publications
  • Qiliang Xin

    Laboratory of Cellular and Developmental Biology, NIDDK, National Institutes of Health, Bethesda, MD 20892, USA

    3 shared publications
  • Xin Chen

    Department of Biology, The Johns Hopkins University, Baltimore, MD 21218, USA

    3 shared publications
  • Binbin Ma

    Howard Hughes Medical Institute, Department of Biology, Johns Hopkins University, Baltimore, MD, USA

    2 shared publications
  • Charles Wu

    Department of Biology, Johns Hopkins University, Baltimore, MD, USA

    2 shared publications

Latest Publications

  • Open Access

    Transient Partial Inhibition of DNA Polymerase α Promotes Chromatin Plasticity and Enhances Human Cell Reprogramming

    by Jian Qi Luo, Yanfeng Yang, Guanghui Yang, Ryan Lee, Binbin Ma, Xin Chen

    Somatic cell reprogramming requires extensive remodeling of epigenomic and transcriptional state, yet the mechanisms that enhance chromatin plasticity during cell-fate conversion remain incompletely understood. Beyond its essential role in genome duplication, DNA replication provides a dynamic window for chromatin remodeling and may therefore influence cellular plasticity during reprogramming. Here, we show that low-dose, transient inhibition of the lagging-strand DNA polymerase α (Polα) complex markedly enhances reprogramming of human peripheral blood mononuclear cells into induced pluripotent stem cells (iPSCs). Fine-tuned inhibition of the catalytic subunit PolA1 increases cell survival under reprogramming-associated stress and enhances cellular resilience to diverse external stresses, preserves genomic stability, and accelerates the acquisition of pluripotent features. PolA1-inhibited cells undergo rapid increases in chromatin accessibility following reprogramming factor delivery and display accelerated progression toward the iPSC state. Consistent with enhanced developmental plasticity, colonies derived from PolA1 inhibitor-treatment display dome-shaped morphology, increased expression of several naïve pluripotency markers such as SUSD2. Integrated imaging and single-nucleus multiomic analyses establish transient PolA1 inhibition as a potent regulator of early chromatin remodeling during reprogramming. Functionally, PolA1 inhibitor-derived iPSC lines maintain stable pluripotency and exhibit enhanced differentiation potential, including increased embryoid body budding and accelerated cardiomyocyte differentiation and maturation. Notably, transient and low-dose PolA1 inhibition alters replication-coupled histone incorporation without reducing DNA replication speed or affecting cell cycle progression. This two-step regime primes human PBMCs for sustained gains in reprogramming efficiency with pre- and post-treatment. Together, these findings identify replication-coupled chromatin regulation as an underappreciated mechanism regulating human cell fate plasticity and demonstrate that transient modulation of Polα can simultaneously enhance epigenomic plasticity and preserve genome stability during reprogramming.

  • Open Access

    Asymmetric histone inheritance regulates olfactory stem cell fates during regeneration

    by Binbin Ma, Guanghui Yang, Jonathan Yao, Charles Wu, Jean Pinckney Vega, Gabriel Manske, Saher Sue Hammoud, Satrajit Sinha, Abhyudai Singh, Haiqing Zhao, et al.

    The olfactory epithelium possesses an adult stem cell population, the horizontal basal cells (HBCs), to permit lifelong tissue regeneration. Here, we show that HBCs exhibit asymmetric inheritance of histone H4 but not H2A-H2B during olfactory epithelium regeneration in mice. Primary HBC cultures further revealed asymmetric histone inheritance for H3 and H3.3. Upon mitotic exit, asymmetric histone inheritance correlates with asynchronous transcription re-initiation and differential enrichment of p63, a key transcription factor for HBC cell fate. Disruption of asymmetric histone inheritance abolishes these asymmetric cellular features and attenuates olfactory epithelium regeneration and smell behavior recovery. Single-cell RNA sequencing of paired HBC daughters in culture further supports asymmetric multilineage cell fate priming. Together, these findings reveal asymmetric histone inheritance in a mammalian adult stem cell lineage and highlight its biological significance in neural tissue regeneration and animal behavior.


  • Open Access

    ZNHIT3 Regulates Translation to Ensure Cell Lineage Differentiation in Mouse Preimplantation Development

    by Guanghui Yang, Qiliang Xin, Jurrien Dean

    Upon fertilization, the mouse zygotic genome is activated and maternal RNAs as well as proteins are degraded. Early developmental programs are built on proteins encoded by zygotic mouse genes that are needed to guide early cell fate commitment. The box C/D snoRNA ribonucleoprotein (snoRNP) complex is required for rRNA biogenesis, ribosome assembly and pre‐mRNA splicing essential for protein translation. Zinc finger, HIT type 3 (encoded by Znhit3) is previously identified as a component in the assembly of the box C/D snoRNP complex. Using gene‐edited mice, it identifies Znhit3 as an early embryonic gene whose ablation reduces protein translation and prevents mouse embryos development beyond the morula stage. The absence of ZNHIT3 leads to decreased snoRNA and rRNA abundance which causes defects of ribosomes and mRNA splicing. Microinjection of Znhit3 cRNA partially rescues the phenotype and confirms that ZNHIT3 is required for mRNA translation during preimplantation development.


  • Open Access

    Asymmetric Histone Inheritance Regulates Olfactory Stem Cell Fates During Regeneration

    by Binbin Ma, Guanghui Yang, Jonathan Yao, Charles Wu, Jean Pinckney Vega, Gabriel Manske, Saher Sue Hammoud, Satrajit Sinha, Abhyudai Singh, Haiqing Zhao, et al.

    To understand epigenetic inheritance in mammals, we investigate cell division modes and histone inheritance patterns in the mouse olfactory epithelium using an injury-induced regeneration model. Horizontal basal cells (HBCs), the adult stem cells in this tissue, undergo asymmetric division, coinciding with asymmetric histone H4 inheritance in vivo. Primary HBCs recapitulate both asymmetric cell division and asymmetric histone inheritance for H4, H3, and H3.3, but not H2A-H2B. Upon mitotic exit, asymmetric histone inheritance correlates with differential enrichment of a key ‘stemness’ transcription factor p63 and asynchronous transcription re-initiation. Single-cell RNA sequencing of paired daughter cells reveals their asymmetric cell fate priming in this multilineage stem cell system. Furthermore, disruption of asymmetric cell division abolishes these asymmetric cellular features, impairing olfactory epithelium regeneration and smell behavior in mice. Together, these findings reveal asymmetric histone inheritance in a mammalian adult stem cell lineage and highlight its biological significance in tissue regeneration and animal behavior.

  • Degradation and translation of maternal mRNA for embryogenesis

    by Guanghui Yang, Qiliang Xin, Jurrien Dean


  • Open Access

    Germ cell-specific eIF4E1b regulates maternal mRNA translation to ensure zygotic genome activation

    by Guanghui Yang, Qiliang Xin, Iris Feng, Di Wu, Jurrien Dean

    Translation of maternal mRNAs is detected before transcription of zygotic genes and is essential for mammalian embryo development. How certain maternal mRNAs are selected for translation instead of degradation and how this burst of translation affects zygotic genome activation remain unknown. Using gene-edited mice, we document that the oocyte-specific eukaryotic translation initiation factor 4E family member 1b (eIF4E1b) is the regulator of maternal mRNA expression that ensures subsequent reprogramming of the zygotic genome. In oocytes, eIF4E1b binds to transcripts encoding translation machinery proteins, chromatin remodelers, and reprogramming factors to promote their translation in zygotes and protect them from degradation. The protein products are thought to establish an open chromatin landscape in one-cell zygotes to enable transcription of genes required for cleavage stage development. Our results define a program for rapid resetting of the zygotic epigenome that is regulated by maternal mRNA expression and provide new insights into the mammalian maternal-to-zygotic transition.


  • Open Access

    Germ-cell specific eIF4E1B regulates maternal RNA translation to ensure zygotic genome activation

    by Guanghui Yang, Qiliang Xin, Iris Feng, Jurrien Dean

    Translation of maternal mRNAs is detected before transcription of zygotic genes and is essential for mammalian embryo development. How certain maternal mRNAs are selected for translation instead of degradation and how this burst of translation affects zygotic genome activation remains unknown. Using gene-edited mice, we document that the eukaryotic translation initiation factor 4E family member 1B (eIF4E1B) is the regulator of maternal mRNA translation that ensures subsequent reprogramming of the zygotic genome. In oocytes, the germ-cell specific eIF4E1B binds to mRNAs encoding chromatin remodeling complexes as well as reprogramming factors to protect them from degradation and promote their translation in zygotes. These protein products establish an open chromatin landscape in one-cell zygotes and enable transcription. Our results define a program for rapid resetting of the zygotic epigenome that is regulated by maternal mRNA translation and provides new insight into the mammalian maternal-to-zygotic transition.

  • Open Access

    Germ-cell specific eIF4E1B regulates maternal RNA translation to ensure zygotic genome activation

    by Guanghui Yang, Qiliang Xin, Iris Feng, Jurrien Dean

    Translation of maternal mRNAs is detected before transcription of zygotic genes and is essential for mammalian embryo development. How certain maternal mRNAs are selected for translation instead of degradation and how this burst of translation affects zygotic genome activation remains unknown. Using gene-edited mice, we document that the eukaryotic translation initiation factor 4E family member 1B (eIF4E1B) is the regulator of maternal mRNA translation that ensures subsequent reprogramming of the zygotic genome. In oocytes, the germ-cell specific eIF4E1B binds to mRNAs encoding chromatin remodeling complexes as well as reprogramming factors to protect them from degradation and promote their translation in zygotes. These protein products establish an open chromatin landscape in one-cell zygotes and enable transcription. Our results define a program for rapid resetting of the zygotic epigenome that is regulated by maternal mRNA translation and provides new insight into the mammalian maternal-to-zygotic transition.


  • Open Access

    Klf4 methylated by Prmt1 restrains the commitment of primitive endoderm

    by Zhen-Yu Zuo, Guang-Hui Yang, Hai-Yu Wang, Shu-Yu Liu, Yan-Jun Zhang, Yun Cai, Fei Chen, Hui Dai, Yi Xiao, Mo-Bin Cheng, et al.

    The second cell fate decision in the early stage of mammalian embryonic development is pivotal; however, the underlying molecular mechanism is largely unexplored. Here, we report that Prmt1 acts as an important regulator in primitive endoderm (PrE) formation. First, Prmt1 depletion promotes PrE gene expression in mouse embryonic stem cells (ESCs). Single-cell RNA sequencing and flow cytometry assays demonstrated that Prmt1 depletion in mESCs contributes to an emerging cluster, where PrE genes are upregulated significantly. Furthermore, the efficiency of extraembryonic endoderm stem cell induction increased in Prmt1-depleted ESCs. Second, the pluripotency factor Klf4 methylated at Arg396 by Prmt1 is required for recruitment of the repressive mSin3a/HDAC complex to silence PrE genes. Most importantly, an embryonic chimeric assay showed that Prmt1 inhibition and mutated Klf4 at Arg 396 induce the integration of mouse ESCs into the PrE lineage. Therefore, we reveal a regulatory mechanism for cell fate decisions centered on Prmt1-mediated Klf4 methylation.


  • Open Access

    Tissue-Engineered “Metastases”: Treatment of Hepatic Colon Tumors with a Dual Action Autotaxin Inhibitor-Lysophosphatidic Acid Receptor Antagonist

    by Guanghui Yang, Honglu Zhang, Glenn D. Prestwich

    Lysophosphatidic acid (LPA) acts via G protein coupled receptors (GPCRs) to regulate critical cellular functions and pathophysiological levels of LPA or its receptors are linked to cancer initiation, progression and metastasis. LPA is biosynthesized by the lysophospholipase D activity of autotaxin(ATX/lysoPLD), a known factor for tumorigenesis. By attenuating both LPA signaling and LPA production, we expected to observe synergistic anti-cancer therapeutic effects. In vitro, treatment of human colon cancer cells (HCT 116) with BrP-LPA, a potent dual action ATX inhibitor and pan-LPA GPCR antagonist, significantly reduced cell proliferation, migration and invasion. Next, a tissue-engineered xenograft model to mimic hepatic metastasis of colon cancer was used to evaluate BrP-LPA efficacy in vivo. HCT 116 cells were suspended in Extracel™, a synthetic extracellular matrix (sECM), and injected directly into the livers of nude mice (n = 8). After 1 week, BrP-LPA in saline buffer was administered for two weeks by intraperitoneal injection (10 mg/kg) twice per week. Controls were injected with saline buffer only. The BrP-LPA treated group showed reduced liver tumor weight (p < 0.05) and reduced tumor volume (p < 0.05) relative to controls. This study is the first demonstration of the effects of a dual action ATX inhibitor/LPA antagonist on colon cancer cells, and the first example of a tissue-engineered hepatic colon cancer “metastases” as a platform for anti-cancer drug evaluation. The results suggest that attenuation of signaling through the LPA pathway offers a promising therapeutic target for reducing colon cancer growth and metastasis.